Phase 2 ALK Gene Mutation Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Alectinib Pharmacokinetic in Patients With NSCLC

ALK Gene MutationNon-small Cell Lung Cancer Stage IIIB

Instituto Nacional de Cancerologia de Mexico45 enrolled1 locationNCT05713006

Recruiting

Phase 2

Pembrolizumab Plus Bevacizumab and Chemotherapy for ALK-rearranged NSCLC With Persistent 5'ALK

Lung AdenocarcinomaImmunotherapyALK Gene Mutation

Hunan Province Tumor Hospital78 enrolled1 locationNCT05266846